OAL

Oriental Aromatics Limited

Specialty and commodity chemicals manufacturer

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

orientalaromatics.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-19

Stock price
₹624.40
Market cap
2,093 Cr
Stock P/E
393.4
P/B
3.16
Dividend yield
0.1%
ROE (FY26)
0.5%
ROCE (FY26)
4.4%
Operating margin (FY26)
3.6%
Debt / equity (FY26)
0.61
OCF / EBITDA (FY26)
3.6%
OCF / EBITDA (3Y)
54.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

OAL (Oriental Aromatics) makes aroma ingredients, camphor and terpene chemicals and fragrance compounds, selling mainly to global fragrance companies and other domestic and international buyers.

Company snapshot

35thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓Dividend payout of 51% — the company returns a meaningful share of profits to shareholders.
Concerns
  • ✗Net margin is very thin at 0.3% — little room for error if costs rise.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales227 Cr197 Cr216 Cr216 Cr237 Cr223 Cr253 Cr226 Cr271 Cr252 Cr282 Cr260 Cr
Operating expenses (approx.)216 Cr183 Cr196 Cr194 Cr208 Cr200 Cr234 Cr207 Cr254 Cr238 Cr263 Cr240 Cr
EBITDA11 Cr14 Cr21 Cr22 Cr29 Cr23 Cr19 Cr18 Cr17 Cr13 Cr19 Cr20 Cr
OPM %4.9%7.1%9.7%10.2%12.1%10.1%7.6%8.0%6.4%5.3%6.9%7.6%
Other income3 Cr2 Cr2 Cr2 Cr2 Cr0.09 Cr0.24 Cr0.27 Cr3 Cr2 Cr4 Cr1.00 Cr
Interest5 Cr7 Cr3 Cr4 Cr6 Cr6 Cr9 Cr8 Cr10 Cr9 Cr9 Cr8 Cr
Depreciation5 Cr5 Cr5 Cr5 Cr5 Cr6 Cr7 Cr8 Cr8 Cr8 Cr8 Cr8 Cr
Profit before tax3 Cr4 Cr14 Cr15 Cr19 Cr10 Cr4 Cr3 Cr3 Cr-2 Cr7 Cr5 Cr
Tax %29.1%41.2%28.3%26.1%23.1%27.7%61.1%80.3%72.8%-4.1%45.7%52.3%
Net profit2 Cr3 Cr10 Cr11 Cr15 Cr7 Cr1 Cr0.50 Cr0.74 Cr-2 Cr4 Cr3 Cr
EPS (₹)₹0.72₹0.78₹3.01₹3.26₹4.39₹2.12₹0.42₹0.15₹0.22₹-0.57₹1.18₹0.75

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales458 Cr506 Cr755 Cr760 Cr709 Cr869 Cr849 Cr836 Cr928 Cr1,031 CrSign in free for the trailing twelve months
Operating expenses (approx.)401 Cr441 Cr640 Cr633 Cr554 Cr776 Cr795 Cr789 Cr835 Cr963 CrSign in free for the trailing twelve months
EBITDA57 Cr65 Cr115 Cr126 Cr155 Cr93 Cr54 Cr47 Cr93 Cr68 CrSign in free for the trailing twelve months
OPM %12.4%12.8%15.2%16.6%21.9%10.7%6.4%5.6%10.1%6.6%Sign in free for the trailing twelve months
Other income7 Cr0.36 Cr1 Cr7 Cr2 Cr4 Cr6 Cr7 Cr3 Cr10 CrSign in free for the trailing twelve months
Interest5 Cr7 Cr13 Cr12 Cr2 Cr4 Cr13 Cr20 Cr25 Cr36 CrSign in free for the trailing twelve months
Depreciation14 Cr15 Cr18 Cr19 Cr17 Cr17 Cr19 Cr20 Cr24 Cr31 CrSign in free for the trailing twelve months
Profit before tax44 Cr43 Cr83 Cr103 Cr137 Cr76 Cr27 Cr14 Cr48 Cr11 CrSign in free for the trailing twelve months
Tax %36.9%41.9%31.3%16.2%25.6%29.8%28.2%35.2%27.9%69.3%Sign in free for the trailing twelve months
Net profit28 Cr25 Cr57 Cr86 Cr102 Cr53 Cr20 Cr9 Cr34 Cr3 CrSign in free for the trailing twelve months
EPS (₹)₹33.14₹29.69₹17.67₹25.61₹30.29₹15.84₹5.87₹2.71₹10.20₹0.98Sign in free for the trailing twelve months
Dividend payout %————8.3%9.5%0.0%18.5%4.9%50.8%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital5 Cr8 Cr17 Cr17 Cr17 Cr17 Cr17 Cr17 Cr17 Cr17 Cr
Reserves311 Cr329 Cr375 Cr447 Cr540 Cr588 Cr608 Cr616 Cr646 Cr648 Cr
Borrowings105 Cr132 Cr173 Cr45 Cr78 Cr139 Cr229 Cr204 Cr352 Cr402 Cr
Other liabilities69 Cr103 Cr107 Cr100 Cr110 Cr120 Cr133 Cr159 Cr130 Cr128 Cr
Total liabilities490 Cr573 Cr673 Cr608 Cr745 Cr865 Cr986 Cr995 Cr1,145 Cr1,194 Cr
Fixed assets (net)154 Cr158 Cr194 Cr189 Cr191 Cr218 Cr209 Cr220 Cr429 Cr395 Cr
CWIP15 Cr40 Cr0.80 Cr2 Cr13 Cr25 Cr52 Cr173 Cr5 Cr5 Cr
Investments——0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Loans & advances——0 Cr0 Cr0.56 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories114 Cr133 Cr203 Cr162 Cr228 Cr287 Cr368 Cr277 Cr365 Cr380 Cr
Trade receivables100 Cr134 Cr160 Cr151 Cr189 Cr195 Cr190 Cr181 Cr188 Cr252 Cr
Cash & bank4 Cr5 Cr4 Cr17 Cr15 Cr7 Cr16 Cr11 Cr11 Cr13 Cr
Other assets102 Cr103 Cr111 Cr87 Cr109 Cr133 Cr151 Cr133 Cr148 Cr150 Cr
Total assets490 Cr573 Cr673 Cr608 Cr745 Cr865 Cr986 Cr995 Cr1,145 Cr1,194 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—16 Cr-23 Cr181 Cr17 Cr-0.81 Cr-22 Cr145 Cr-34 Cr2 Cr
Cash from investing—-31 Cr-12 Cr-10 Cr-35 Cr-59 Cr-46 Cr-99 Cr-87 Cr-12 Cr
Cash from financing—15 Cr36 Cr-159 Cr16 Cr51 Cr78 Cr-52 Cr121 Cr12 Cr
Net cash flow—0.21 Cr-0.20 Cr12 Cr-2 Cr-9 Cr9 Cr-5 Cr-0.04 Cr3 Cr
Free cash flow (OCF − Capex)—-15 Cr-36 Cr171 Cr-18 Cr-60 Cr-69 Cr46 Cr-121 Cr-9 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %11.8%10.7%17.0%22.6%21.9%10.7%4.7%4.1%7.2%4.4%
ROE %8.8%7.4%14.6%18.6%18.3%8.8%3.2%1.4%5.2%0.5%
Debtor days80977773978281797489
Inventory days142146141122200170212190216213
Days payable41673742624850564547
Cash conversion cycle181176181153234203244213245256
OCF / EBITDA %—24.8%-20.4%143.1%11.2%-0.9%-41.1%309.3%-36.7%3.6%
OCF / EBITDA % (3 years)———56.7%44.1%52.8%-1.9%63.0%45.5%54.4%
Debt / equity0.330.390.440.100.140.230.370.320.530.61
Current ratio2.441.701.793.183.012.992.181.931.751.60
Net debt / EBITDA1.771.971.470.220.401.433.934.123.665.72